Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion

BACKGROUND: The biological behavior of epithelial ovarian cancer (EOC) is unique since EOC cells metastasize early to the peritoneum. Thereby, new anti-target agents designed to block trans-coelomic dissemination of EOC cells may be useful as anti-metastatic drugs. The Urokinase Plasminogen Activato...

Descripción completa

Detalles Bibliográficos
Autores principales: Minopoli, Michele, Botti, Giovanni, Gigantino, Vincenzo, Ragone, Concetta, Sarno, Sabrina, Motti, Maria Letizia, Scognamiglio, Giosuè, Greggi, Stefano, Scaffa, Cono, Roca, Maria Serena, Stoppelli, Maria Patrizia, Ciliberto, Gennaro, Losito, Nunzia Simona, Carriero, Maria Vincenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839174/
https://www.ncbi.nlm.nih.gov/pubmed/31703596
http://dx.doi.org/10.1186/s13046-019-1465-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839174/
https://www.ncbi.nlm.nih.gov/pubmed/31703596
http://dx.doi.org/10.1186/s13046-019-1465-8

Ejemplares similares